Latest research progress on anticancer effect of baicalin and its aglycone baicalein
- PMID: 35908250
- DOI: 10.1007/s12272-022-01397-z
Latest research progress on anticancer effect of baicalin and its aglycone baicalein
Abstract
Cancer, which is a leading cause of deaths around the world, is characterized by genetic mutations and epigenetic changes. Baicalin and its aglycone baicalein, the major bioactive flavones derived from the dried root of Scutellaria baicalensis Georigi, belong to flavonoid compounds. Many studies demonstrated that both of them exhibited remarkable promising anticancer activities. This study summarized potential anticancer mechanisms of baicalin and baicalein including induction of apoptosis, initiation of cell cycle arrest, suppression of metastasis, induction of autophagy, and regulation of immunity. Combination strategies involving baicalin or baicalein as chemotherapeutic adjuvants, clinical trial and safety were also discussed. In addition, we compared the difference in their anticancer effects. Interestingly, baicalein showed quicker and stronger inhibitory effects on multiple cancers than those of baicalin, probably due to its smaller size and high lipophilicity which contribute to fast absorption and improve ability to penetrate cells. Taken together, both baicalin and baicalein are effective in treating cancer with good tolerance. However, deglycosylation of baicalin to baicalein was found to have stronger anticancer potential.
Keywords: Anticancer effect; Baicalein; Baicalin; Combination strategy; Mechanisms.
© 2022. The Pharmaceutical Society of Korea.
Similar articles
-
Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors.Eur J Med Chem. 2017 Jan 27;126:844-852. doi: 10.1016/j.ejmech.2016.11.058. Epub 2016 Dec 1. Eur J Med Chem. 2017. PMID: 27960146 Review.
-
Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives.Pharmacol Res. 2024 Jan;199:107032. doi: 10.1016/j.phrs.2023.107032. Epub 2023 Dec 5. Pharmacol Res. 2024. PMID: 38061594 Review.
-
Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies.Cancer Lett. 2014 Nov 1;354(1):5-11. doi: 10.1016/j.canlet.2014.08.003. Epub 2014 Aug 13. Cancer Lett. 2014. PMID: 25128647 Free PMC article. Review.
-
Two-Armed Activation of Bone Mineral Deposition by the Flavones Baicalin and Baicalein, Encapsulated in Polyphosphate Microparticles.Am J Chin Med. 2017;45(3):533-555. doi: 10.1142/S0192415X1750032X. Epub 2017 Apr 2. Am J Chin Med. 2017. PMID: 28367715
-
Baicalin and its aglycone: a novel approach for treatment of metabolic disorders.Pharmacol Rep. 2020 Feb;72(1):13-23. doi: 10.1007/s43440-019-00024-x. Epub 2020 Jan 8. Pharmacol Rep. 2020. PMID: 32016847
Cited by
-
Immuno-modulatory role of baicalin in atherosclerosis prevention and treatment: current scenario and future directions.Front Immunol. 2024 Apr 18;15:1377470. doi: 10.3389/fimmu.2024.1377470. eCollection 2024. Front Immunol. 2024. PMID: 38698839 Free PMC article. Review.
-
Advances in the role of baicalin and baicalein in colon cancer: mechanisms and therapeutic potential.Discov Oncol. 2025 May 22;16(1):860. doi: 10.1007/s12672-025-02719-5. Discov Oncol. 2025. PMID: 40404880 Free PMC article. Review.
-
Exploring the therapeutic potential and in vitro validation of baicalin for the treatment of triple-negative breast cancer.Front Pharmacol. 2025 Apr 28;16:1530056. doi: 10.3389/fphar.2025.1530056. eCollection 2025. Front Pharmacol. 2025. PMID: 40356970 Free PMC article.
-
Multiple roles of baicalin and baicalein in the regulation of colorectal cancer.Front Pharmacol. 2024 Feb 5;15:1264418. doi: 10.3389/fphar.2024.1264418. eCollection 2024. Front Pharmacol. 2024. PMID: 38375035 Free PMC article. Review.
-
The Anti-Diabetic Potential of Baicalin: Evidence from Rodent Studies.Int J Mol Sci. 2023 Dec 28;25(1):431. doi: 10.3390/ijms25010431. Int J Mol Sci. 2023. PMID: 38203600 Free PMC article. Review.
References
-
- Abbott M, Ustoyev Y (2019) Cancer and the immune system: The history and background of immunotherapy. Semin Oncol Nurs 35:150923. https://doi.org/10.1016/j.soncn.2019.08.002 - DOI - PubMed
-
- Alzahrani AS (2019) PI3K/Akt/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol 59:125–132. https://doi.org/10.1016/j.semcancer.2019.07.009 - DOI - PubMed
-
- Bie BB, Sun J, Li J, Guo Y, Jiang W, Huang C, Yang J, Li ZF (2017) Baicalein, a natural anti-cancer compound, alters microRNA expression profiles in Bel-7402 human hepatocellular carcinoma cells. Cell Physiol Biochem 41:1519–1531. https://doi.org/10.1159/000470815 - DOI - PubMed
-
- Bukowski K, Kciuk M, Kontek R (2020) Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci 21:3233. https://doi.org/10.3390/ijms21093233 - DOI - PMC
-
- Cai FF, Wang XF, Zhou QM, Lu YY, Su SB (2021) Baicalein regulates Rho-ROCK-MLC pathway to inhibit the growth and metastasis of breast cancer. Nat Prod Res Dev 33:570. https://doi.org/10.16333/j.1001-6880.2021.4.005 - DOI
Publication types
MeSH terms
Substances
Grants and funding
- 2020-703/the Cooperation Projects of Chunhui Plan of the Ministry of Education of China
- 2021JDTD0008/the Youth Science and Technology Innovation Research Ream of the Science and Technology Department of Sichuan province of China
- 2020YJ0336/basic research fund of the Science and Technology Department of Sichuan province of China
- 2020YJ0373/basic research fund of the Science and Technology Department of Sichuan province of China
- 2019LZXNYDZ07/the Joint Fund of Luzhou City and Southwest Medical University
LinkOut - more resources
Full Text Sources
Medical